 early weeks following these events. A meta-analysis of
eight randomized clinical trials including 20,728 patients
demonstrated that short-term (<3 months) dual antiplatelet therapy with aspirin and clopidogrel compared with
aspirin alone signiﬁcantly decreased risk of recurrent stroke
but it did not increase risk of hemorrhagic complications.
Relative to monotherapy with aspirin, dual therapy with
aspirin and clopidogrel reduced risk